Further the dermalogical system application may increase cellular activity and help heal tissue faster and facilitate the delivery, uptake and use in the cell of the cosmetics, medica tions, or chemicals 22A used.

The apparatus 10, 320, 360, 360, 400, 460 may be employed to apply cosmetics, medications and/or other actives directly to the skin and maintain their presence long-term while using LED or other actinic light to increase their effect on the cells and tissue in the body.

Chemicals 22A may include cosmetics, medications and other actives appropriate for dermalogical cells including AHA's (alpha hydroxy acid), natural oils, aloe vera com pounds, collagen boosters, bt, chitosan, daeses, endorphins, photodynamic drugs (PDT) like (Photofrin or ALA), vita mins A, C E or others, kojic acid, retinals or other exfoliant, salicylic acid, anti oxidants or other youth boosters and anti 20 aging cosmetic or medications, antiseptic, antibiotics, anti cancer agents, aroma therapy agents, fruit and vegetable extracts, anti-inflanimatory agents, pain relievers, hormones, depilatories, and others, but the scope of this invention is not limited to these alone but can include any helpful medication, herbal formula or active compound for the skin and/or other tissues.

In an embodiment the internal spring 924M (FIG. llC) may force extension ofthe pin 924G to maintain electrical conduction with the MLM 922 as the needle assembly 924F is moved (recessed and deployed to various depths).

As noted the DTA 900 SGC 911 RFSG 911A, NDMC 9118, and PSG 911 C may enable a user or clinician to select a variety of operational parameters to deliver a desired combination of electrical, light (photonic), and mechanical (needle) therapy to dermalogical tissue.

The apparatus 360 may include a handle 330, an elastic section 333, an electrical conductive interface 390, internal wire(s) 331, signal generator 370, switch 375, and plate 350.

The apparatus 10, 320, 360, 360, 400, 460, light application may enable cosmetic or medication or other active chemicals 22A on dermatological cells for longer time periods while prevent- ing dehydration of the applied substances.

Further the dermatological system application may increase cellular activity and help heal tissue faster and facilitate the delivery, uptake and use in the cell of the cosmetics, medications, or chemicals 22A used.

The apparatus 10, 320, 360, 360, 400, 460 may be employed to apply cosmet ics, medications and/or other actives directly to the skin and 30 maintain their presence long-term while using LED or other actinic light to increase their effect on the cells and tissue in the body.

Chemicals 22A may include cosmetics, medications and 35 other actives appropriate for dermatological cells including AHA's (alpha hydroxy acid), natural oils, aloe vera com pounds, collagen boosters, bt, chitosan, daeses, endorphins, photodynamic drugs (PDT) like (Photofrin or ALA), vita mins A, C E or others, kojic acid, retinals or other exfoliant, 40 salicylic acid, anti oxidants or other youth boosters and anti aging cosmetic or medications, antiseptic, antibiotics, anti cancer agents, aroma therapy agents, fruit and vegetable extracts, anti-inflanmiatory agents, pain relievers, hormones, depilatories, and others, but the scope of this invention is not 45 limited to these alone but can include any helpful medica tion, herbal formula or active compound for the skin and/or other tissues.